Furthermore, liraglutide enhances the susceptibility of gemcitabine-resistant pancreatic cancer cells to apoptosis by downregulating ATP-binding cassette transporter G2 (ABCG2) via NF-B signaling [75]
Of course, the medication still works in the same way as the active ingredient is still working as intended, but the licensing dictates what each medication should be used for
The Bottom Line GHK-Cu sits in a strange spot in the peptide research world genuinely old research (Pickart's earliest work goes back to the 1970s), genuinely broad mechanistic reach (thousands of modulated genes), but still a compound where the human clinical trial base lags behind the mechanistic and cell-culture data
[1] [2] Understanding its relationship with kidney function is essential for both patients and healthcare professionals, particularly as many individuals with diabetes have concurrent renal impairment
Fritsch M, Gnther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, Schiffmann LM, Stair N, Stocks H, Seeger JM, et al
Kidney Int 2024;105(4s):S117s314